Richard Larson

Section of Hematology/Oncology, The University of Chicago Pritzker School of Medicine, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Hematology > Leukemia & Proliferative Disorders of Hematic Cells (since 15 November 2007)

All recent recommendations

• 3.0
  Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.
  Recommended by Richard Larson with Olatoyosi M Odenike
  
• 3.0
  Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
  Recommended by Richard Larson with Olatoyosi Odenike